Bilateral plantar fibromatosis complicated by Dupuytren's contracture

Skin marker for MR-only surface high-dose-rate brachytherapy

Purpose

Recent advances in surface high-dose-rate (HDR) brachytherapy imaging indicate that flap applicators, human skin, and fibromatosis can be visualized using MRI. Complete MR-only surface brachytherapy workflows would require skin marker identification to define clinical target edges. However, CT markers are not detected on MR images, and common MR markers are unsuitable for continuous surface target tracing. In this paper, we proposed an alternative skin marker that was evaluated for MRI and CT detectability and contourability using a brachytherapy treatment planning system (TPS).

Material and methods

Commercially obtained silicone rubber tubes of 2 or 3 mm diameter were taped on the hand of an anthropomorphic phantom, a healthy volunteer, and three palmar fascial fibromatosis patients. Subjects were imaged with an optimized 3D pointwise encoding time reduction with radial acquisition (PETRA) sequence, and a volumetric interpolated breath-hold examination (VIBE) sequence with Dixon reconstruction. Additionally, patients underwent standard CT imaging. Obtained images were reviewed for tube conspicuity, and tubes were tracked on axial views using Oncentra Brachy TPS. Independent tube and muscle reference contours were drawn in MIM for quantitative analysis, considering the three orthogonal imaging planes.

Results and Conclusions

Silicone rubber tubes were detected with positive signal on PETRA, VIBE, and CT images. Among the MR series, Dixon VIBE fat-only showed the highest contrast against muscle tissue and the best separation from human skin, followed by DIXON opposed-phase. 3 mm diameter tubes were tracked better by TPS than 2 mm diameter ones. Considering MR images in the three orthogonal planes in MIM was more helpful for localizing the entire tube than using axial images only in TPS. All obtained contour shapes generally agreed with the known tube positions. Overall, solid silicone rubber tubes of 3 mm diameter represent a suitable skin marker alternative to CT markers for MR-only surface HDR brachytherapy.

Ledderhose's Disease: An Up-to-Date Review of a Rare Non-Malignant Disorder

Plantar fibromatosis (or Ledderhose's disease) is a rare benign condition, difficult to treat, defined by gradual-growing nodules in the central medial part of the plantar fascia, with the possibility of sclerosis and shrinkage of the entire fascia or, rarely, contractures of the toes. From a histopathological point of view, it is linked to Dupuytren's contracture of the hand and Peyronie's disease of the penis, being part of a large group of fibromatoses, based on a proliferation of collagen and fibroblasts. Its etiology is still not fully understood, even though it has been associated with trauma, diabetes mellitus, use of anticonvulsants, frozen shoulder, alcohol consumption, and liver disease. Typically, ultrasound confirms the diagnosis, and magnetic resonance imaging is used for more aggressive and advanced types. Several conservative treatment techniques, such as steroid injections, verapamil, imatinib, radiation therapy, extracorporeal shock wave therapy, tamoxifen, sorafenib, mitomycin C, and collagenase, have been documented. When non-operative care fails, surgical measures may be considered, even though recurrence is expected. We attempted to provide a better understanding of this disease by covering all of the important aspects: its history, clinical and radiologic findings, diagnosis, pathophysiology features, conservative and surgical treatment, recurrence rate, and prognosis.